These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6426199

  • 41. Effect of manganese exposure on the neuroendocrine system in welders.
    Kim EA, Cheong HK, Joo KD, Shin JH, Lee JS, Choi SB, Kim MO, Lee IuJ, Kang DM.
    Neurotoxicology; 2007 Mar; 28(2):263-9. PubMed ID: 16950514
    [Abstract] [Full Text] [Related]

  • 42. The functional state of the hypothalamo-pituitary axis after high-dose oestrogen therapy in excessively tall girls.
    Hanker JP, Schellong G, Schneider HP.
    Acta Endocrinol (Copenh); 1979 May; 91(1):19-29. PubMed ID: 222099
    [No Abstract] [Full Text] [Related]

  • 43. [Hormonal response following the use of gonadotropin-releasing hormone, estradiol and gestil in sheep].
    Batzhargalin E.
    Vet Med Nauki; 1985 May; 22(9):60-6. PubMed ID: 3909630
    [Abstract] [Full Text] [Related]

  • 44. Effects of steroids on basal and GnRH-induced LH and FSH secretion by dispersed pituitary cells of immature female lambs.
    Peclaris GM.
    Endocrinol Exp; 1980 Dec; 14(4):258-68. PubMed ID: 6780307
    [Abstract] [Full Text] [Related]

  • 45. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
    Hochner-Celnikier D, Zylber-Haran E, Shilo S, Palti Z, Spitz IM.
    Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
    [Abstract] [Full Text] [Related]

  • 46. [Gonadotropin-releasing hormone (GnRH) in selecting patients for varicocelectomy].
    Segenreich E, Israilov S, Shmueli J, Niv E, Servadio C.
    Harefuah; 1997 Mar 02; 132(5):330-2, 383. PubMed ID: 9153874
    [Abstract] [Full Text] [Related]

  • 47. [Advantages and limitations of steroid contraception: considerations on 14 cases of post-pill amenorrhea observed by the author].
    Faggiano M, Criscuolo T, Venditto T, Striano S, Quarto C, Sinisi AA.
    Arch Ostet Ginecol; 1978 Mar 02; 83(5-6):143-55. PubMed ID: 120737
    [No Abstract] [Full Text] [Related]

  • 48. Inhibitory effects of RU 16117, a potent estrogen antagonist, on the estrous cycle in the rat.
    Ferland L, Labrie F, Kelly PA, Raynaud JP.
    Biol Reprod; 1978 Feb 02; 18(1):99-104. PubMed ID: 342001
    [No Abstract] [Full Text] [Related]

  • 49. Luteinizing hormone-releasing hormone and thyrotropin-releasing hormone stimulation studies in patients given clomipramine or 'depot' neuroleptics.
    Huws D, Groom GV.
    Postgrad Med J; 1977 Feb 02; 53 Suppl 4():175-81. PubMed ID: 414217
    [No Abstract] [Full Text] [Related]

  • 50. [The double GnRH-TRH test following control of lactation with ethinyl estradiol sulfonate after abortion, early and term labor].
    Göretzlehner G, Leminski A, Lembke J, Wodrig W, Weber A.
    Gynakol Rundsch; 1989 Feb 02; 29 Suppl 2():309-12. PubMed ID: 2515123
    [No Abstract] [Full Text] [Related]

  • 51. Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release.
    Römmler A, Baumgarten S, Schwartz U, Hammerstein J.
    Contraception; 1982 Jun 02; 25(6):619-27. PubMed ID: 6214371
    [Abstract] [Full Text] [Related]

  • 52. Effects of estrogen on plasma and pituitary gonadotropins and prolactin, and on hypothalamic releasing and inhibiting factors.
    Ajika K, Krulich L, Fawcett CP, McCann SM.
    Neuroendocrinology; 1972 Jun 02; 9(5):304-15. PubMed ID: 4555305
    [No Abstract] [Full Text] [Related]

  • 53. [Effect of ethinyl estradiol sulfonate/norethisterone acetate on gonadotropin secretion in pubertal girls].
    Rudolf K, Kunkel S, Meissner J, Rüting M.
    Zentralbl Gynakol; 1985 Jun 02; 107(22):1345-52. PubMed ID: 3937370
    [Abstract] [Full Text] [Related]

  • 54. Transcortin as an indicator of estrogenic potency in oral contraceptives.
    Carol W, Börner A, Klinger G, Greinke C.
    Endokrinologie; 1980 Mar 02; 75(2):167-72. PubMed ID: 6156820
    [Abstract] [Full Text] [Related]

  • 55. [Continual measurements of LH, FSH, and prolactin in the plasma after the administration of gonadotropin-releasers and catecholamin-precursors].
    Schneider HP.
    Acta Endocrinol Suppl (Copenh); 1971 Mar 02; 152():3. PubMed ID: 4927549
    [No Abstract] [Full Text] [Related]

  • 56. Endocrine studies in patients with isolated gonadotrophin-releasing hormone deficiency.
    Norman RJ, Naidoo C, Reddi K, Vink GJ, Naidoo BN, Joubert SM.
    S Afr Med J; 1986 Aug 02; 70(3):152-5. PubMed ID: 3090716
    [Abstract] [Full Text] [Related]

  • 57. Klinefelter's syndrome: effects of short-term testosterone administration on hypothalamic-pituitary axis function.
    Forti G, Borghi A, Giusti G, Pazzagli M, Giannotti P, Mannelli M, Fusi S, Serio M.
    J Endocrinol Invest; 1978 Jul 02; 1(3):239-44. PubMed ID: 389995
    [No Abstract] [Full Text] [Related]

  • 58. Prospective studies of the gonadotropin responses to graded injections of gonadotopin-releasing factor in women using a low-estrogen type oral contraceptive for three months.
    Spellacy WN, Kalra PS, Birk SA.
    Fertil Steril; 1979 Dec 02; 32(6):661-3. PubMed ID: 389678
    [Abstract] [Full Text] [Related]

  • 59. Endocrine properties and mechanism of action of oral contraceptives.
    Saunders FJ.
    Fed Proc; 1970 Dec 02; 29(3):1211-9. PubMed ID: 4910270
    [No Abstract] [Full Text] [Related]

  • 60. [Gonadotropic function during its use and after its cessation of a triphasic combination of gestodene].
    Levaillant JM, Levaillant C, Colin MC, Rotten D.
    Rev Fr Gynecol Obstet; 1988 Oct 02; 83(10):655-61. PubMed ID: 3144031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.